ZA936723B - Pharmaceutical preparations for lowering homocysteine levels - Google Patents

Pharmaceutical preparations for lowering homocysteine levels

Info

Publication number: ZA936723B
Authority: ZA; South Africa
Prior art keywords: pharmaceutical preparations; homocysteine levels; lowering homocysteine; lowering; levels
Prior art date: 1992-09-14

Application number

ZA936723A

Other languages

English (en)

Inventor

Willem Jacob Serfontein

Original Assignee

Vesta Med Pty Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-09-14

Filing date

1993-09-13

Publication date

1995-08-14

1993-09-13 Application filed by Vesta Med Pty Ltd filed Critical Vesta Med Pty Ltd

1995-08-14 Publication of ZA936723B publication Critical patent/ZA936723B/xx

Links

FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 title 1
239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Obesity (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Nutrition Science (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

ZA936723A 1992-09-14 1993-09-13 Pharmaceutical preparations for lowering homocysteine levels ZA936723B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ZA926990		1992-09-14

Publications (1)

Publication Number	Publication Date
ZA936723B true ZA936723B (en)	1995-08-14

Family

ID=25582104

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA936723A ZA936723B (en)	1992-09-14	1993-09-13	Pharmaceutical preparations for lowering homocysteine levels

Country Status (5)

Country	Link
EP (1)	EP0595005A1 (de)
JP (1)	JPH06192105A (de)
CN (1)	CN1087517A (de)
CA (1)	CA2105177A1 (de)
ZA (1)	ZA936723B (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0689834A3 (de)	1994-07-01	1996-06-05	Willem Jacob Serfontein	Nahrungs- oder Futterzusatz, der Vitamine und Mineralstoffe mit verzögerter Wirkstoffabgabe enthält
WO1996006632A1 (en) *	1994-09-01	1996-03-07	Allied Medical Research Associates	Compositions and methods for delivery of polypeptides
US6265391B1 (en)	1995-10-17	2001-07-24	Upsher-Smith Laboratories, Inc.	Method for preventing peripheral nerve damage
US5932624A (en) *	1995-10-17	1999-08-03	Herbert; Victor D.	Vitamin supplement composition
JP3602141B2 (ja)	1996-01-31	2004-12-15	サウス、アラバマ、メディカル、サイエンス、ファウンデーション	還元されたフォレートの天然異性体を含む食品およびビタミン製剤
DE19649730A1 (de) *	1996-08-08	1998-02-12	Eu Rho Pharma Gmbh	Mittel zur Stärkung des menschlichen Organismus
US6008221A (en) *	1996-11-06	1999-12-28	Bristol-Myers Squibb Company	Method for treating Alzheimer's disease with folic acid
CH693255A5 (de) *	1997-06-13	2003-05-15	Eprova Ag	Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
DE19812753C1 (de) *	1998-03-23	1999-09-09	Schieffer Arzneimittel Gmbh Dr	Zusammensetzung zur pharmazeutischen Anwendung und/oder zur Ernährungsergänzung bei Mensch oder Tier
WO1999063943A2 (en) *	1998-06-12	1999-12-16	Craig Anthony Cooney	Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
US6475514B1 (en)	1998-12-03	2002-11-05	Andrew Blitzer	Athletic patch
US6210686B1 (en) *	1998-12-18	2001-04-03	Beth Israel Deaconess Medical Center	Dietary supplement and method for lowering risk of heart disease
US6914073B2 (en) *	1999-03-18	2005-07-05	Bristol Myers Squibb Company	Vitamin formulation for cardiovascular health
GB9906740D0 (en)	1999-03-23	1999-05-19	Kilgowan Limited	Oral combinations of hydroxocobalamin and folic acid
AU783656B2 (en) *	1999-09-02	2005-11-24	Nostrum Pharmaceuticals, Inc.	Controlled release oral dosage suitable for oral administration
FI19992239A7 (fi) *	1999-10-18	2001-04-19	Jurilab Ltd Oy	Ravintotäydennys
WO2001030352A1 (en) *	1999-10-28	2001-05-03	Cary Pharmaceuticals Inc.	High dose folic acid for the treatment of hyperhomocysteinemia
DE10053155A1 (de) *	2000-10-26	2002-05-08	Erika Jungkeit	Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte
WO2002083151A2 (en) *	2000-12-14	2002-10-24	Tufts University	Compositions and methods for treating an arthritic condition
JP4611622B2 (ja) *	2002-07-11	2011-01-12	第一三共株式会社	血中脂質改善又は血中ホモシステイン低下のための医薬組成物
WO2004006919A1 (ja) *	2002-07-11	2004-01-22	Sankyo Company, Limited	血中脂質改善又は血中ホモシステイン低下のための医薬組成物
JP2004231585A (ja) *	2002-12-05	2004-08-19	Fancl Corp	生体内ホモシステインレベル低減用および上昇抑制用組成物
EP1937269A1 (de) *	2004-05-09	2008-07-02	Amal Mohamed Zakaria Al-Ansary	Verfahren zur herstellung von kontrazeptiven formulierungen
US20050272691A1 (en) *	2004-06-04	2005-12-08	Eaton Kevin P	Treatment of dermatological conditions
DE102005001479A1 (de)	2005-01-12	2006-07-20	Synavit Gmbh	Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005009379A1 (de)	2005-03-01	2006-09-07	Synavit Gmbh	Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
CN100349578C (zh) *	2005-04-29	2007-11-21	朱舜时	治疗萎缩性胃炎的药物组合物
JP2007106703A (ja) *	2005-10-14	2007-04-26	Nutri Kk	血管障害の予防および治療組成物
US7282225B1 (en)	2006-09-27	2007-10-16	Occular Technologies, Inc.	Composition and methods for improving retinal health
DE102007003795A1 (de) *	2007-01-25	2008-07-31	Phrontier S.A.R.L.	Verwendung von Folsäure, Vitamin B6 und Vitamin B12
KR101290514B1 (ko) *	2007-10-25	2013-07-26	뉴트리 가부시키가이샤	혈중의 당, 말론디알데히드 수식 ｌｄｌ, 호모시스테인 및/또는 ｃ 반응성 단백질을 저감시키기 위한 조성물
CN101584380B (zh) *	2009-06-19	2011-08-10	山西新立源生物科技有限公司	复合甜菜碱的制备方法
CN102898321B (zh) *	2011-07-24	2015-10-28	上海海嘉诺医药发展股份有限公司	一种制备n-丁氧草酰丙氨酸丁酯的方法
CN102429920A (zh) *	2011-11-30	2012-05-02	胡志超	一种多关联降血酸组合物及其制备方法
EP2674159B1 (de) *	2012-06-15	2016-04-27	Phrontier S.A.R.L.	Pharmazeutische Zusammensetzung für die Leber-Regeneration
KR20180059542A (ko) *	2015-10-07	2018-06-04	디에스엠 아이피 어셋츠 비.브이.	멀티비타민 압출물
KR20180121962A (ko) *	2016-03-22	2018-11-09	발켐 코포레이션	콜린을 포함하는 조성물
US11291683B2 (en)	2016-04-01	2022-04-05	Access Business Group International Llc	Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1767499A1 (de) *	1968-05-16	1971-09-09	Merck Patent Gmbh	Verfahren zur Herstellung haltbarer Vitaminzubereitungen
GB8900924D0 (en) *	1989-01-17	1989-03-08	Amco Chemie Handel	Compositions for use in enzyme deficiencies
NZ222664A (en) *	1986-11-29	1990-06-26	Vesta Med Pty Ltd	Pharmaceutical compositions containing pyridoxal as a source of vitamin b6
BR9105986A (pt) *	1990-02-05	1992-11-10	Univ Texas	Formulacao de liberacao por tempo de vitaminas,minerais e outros suplementos beneficos
GB2254556B (en) *	1991-04-11	1995-04-12	Fisons Plc	Formulations containing linolenic acid

1993
- 1993-09-13 ZA ZA936723A patent/ZA936723B/xx unknown
- 1993-09-13 CN CN93117372A patent/CN1087517A/zh active Pending
- 1993-09-13 CA CA002105177A patent/CA2105177A1/en not_active Abandoned
- 1993-09-13 JP JP5227026A patent/JPH06192105A/ja active Pending
- 1993-09-14 EP EP93114762A patent/EP0595005A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
CN1087517A (zh)	1994-06-08
JPH06192105A (ja)	1994-07-12
CA2105177A1 (en)	1994-03-15
EP0595005A1 (de)	1994-05-04

Publication	Publication Date	Title
ZA936723B (en)	1995-08-14	Pharmaceutical preparations for lowering homocysteine levels
PH30215A (en)	1997-02-05	Pharmaceutical compounds
GB9319500D0 (en)	1993-11-03	Pharmaceutical composition
GB2272375B (en)	1996-02-14	Pharmaceutical composition
HU9303261D0 (en)	1994-03-28	Pharmaceutical compounds
ZA931944B (en)	1994-09-18	Pharmaceutical compounds
GB9201639D0 (en)	1992-03-11	Pharmaceutical formulations
PL308307A1 (en)	1995-07-24	3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
GB9221707D0 (en)	1992-12-02	Pharmaceutical composition
ZA94155B (en)	1995-07-11	Pharmaceutical composition
ZA935078B (en)	1994-02-07	Pharmaceutical composition
GB9224169D0 (en)	1993-01-06	Pharmaceutical compounds
GB9222242D0 (en)	1992-12-09	Pharmaceutical preparations for lowering homocysteine levels
GB9226724D0 (en)	1993-02-17	Pharmaceutical compounds
ZA924061B (en)	1993-02-24	Pharmaceutical composition
ZA935931B (en)	1994-03-07	Pharmaceutical composition
GB9211379D0 (en)	1992-07-15	Pharmaceutical compounds
GB9213058D0 (en)	1992-08-05	Pharmaceutical compounds
GB9226895D0 (en)	1993-02-17	Pharmaceutical compounds
GB9218092D0 (en)	1992-10-14	Pharmaceutical compounds
GB9218112D0 (en)	1992-10-14	Pharmaceutical compounds
GB9218091D0 (en)	1992-10-14	Pharmaceutical compounds
ZA931332B (en)	1994-08-25	Pharmaceutical compounds
GB9218090D0 (en)	1992-10-14	Pharmaceutical compounds
GB9209028D0 (en)	1992-06-10	Pharmaceutical compounds